glp 1 drugs and cancer GLP-1 linked to lower rates of some cancers GLP-1 Drugs Appear to Prevent

Semaglutide for weight loss is dosed higher (2.4 mg) than Ozempic for diabetes (0.51 mg)

Back Couzin-Frankel, J (22 Sept 2023), 'Sidelined', Science , 381/6664, 1274-77

For patients who have not responded well to semaglutide or tirzepatide, or who have specific reasons to prefer a daily liraglutide regimen, Saxenda remains a valid clinical option

These factors reinforce the need for individualized treatment plans rather than broad, unsupervised use

These results suggest that mild to moderate hyperglycemia is required for the insulinotropic effect of GIP in nondiabetic subjects, acting as a mechanism to prevent reactive hypoglycemia following the consumption of fatty foods

Baker, T